Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly.Barrons • 09/03/24
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right NowThe Motley Fool • 08/31/24
Eli Lilly Could Become the First $1 Trillion Drug Stock. How Weight-Loss Drugs Can Get It There.Barrons • 08/30/24
Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your MindThe Motley Fool • 08/30/24
Lilly (LLY) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 08/29/24
Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?The Motley Fool • 08/29/24
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling DrugsZacks Investment Research • 08/28/24
Eli Lilly Option Trade Could Return $1,650, If Stock Doesn't Go HaywireInvestors Business Daily • 08/28/24
Hims & Hers Health Stock Takes Hit as Eli Lilly Offers Cheaper Weight-Loss DrugInvestopedia • 08/27/24
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund's 2024 Corporate Membership Program at ‘Champion' LevelGlobeNewsWire • 08/27/24
Eli Lilly slashes price of weight-loss drug Zepbound by 50% to sell in smaller dosesNew York Post • 08/27/24